A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity

Virus-encoded microRNAs were first reported in the Epstein–Barr virus in 2004. Subsequently, a few hundred viral miRNAs have been identified, mainly in DNA viruses belonging to the <i>herpesviridae</i> family. To date, only 30 viral miRNAs encoded by RNA viruses are reported by miRBase....

Full description

Bibliographic Details
Main Authors: Francesco Greco, Elisa Lorefice, Claudia Carissimi, Ilaria Laudadio, Fabiola Ciccosanti, Martina Di Rienzo, Francesca Colavita, Silvia Meschi, Fabrizio Maggi, Gian Maria Fimia, Valerio Fulci
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Non-Coding RNA
Subjects:
Online Access:https://www.mdpi.com/2311-553X/9/3/33
_version_ 1797593267227852800
author Francesco Greco
Elisa Lorefice
Claudia Carissimi
Ilaria Laudadio
Fabiola Ciccosanti
Martina Di Rienzo
Francesca Colavita
Silvia Meschi
Fabrizio Maggi
Gian Maria Fimia
Valerio Fulci
author_facet Francesco Greco
Elisa Lorefice
Claudia Carissimi
Ilaria Laudadio
Fabiola Ciccosanti
Martina Di Rienzo
Francesca Colavita
Silvia Meschi
Fabrizio Maggi
Gian Maria Fimia
Valerio Fulci
author_sort Francesco Greco
collection DOAJ
description Virus-encoded microRNAs were first reported in the Epstein–Barr virus in 2004. Subsequently, a few hundred viral miRNAs have been identified, mainly in DNA viruses belonging to the <i>herpesviridae</i> family. To date, only 30 viral miRNAs encoded by RNA viruses are reported by miRBase. Since the outbreak of the SARS-CoV-2 pandemic, several studies have predicted and, in some cases, experimentally validated miRNAs originating from the positive strand of the SARS-CoV-2 genome. By integrating NGS data analysis and qRT-PCR approaches, we found that SARS-CoV-2 also encodes for a viral miRNA arising from the minus (antisense) strand of the viral genome, in the region encoding for ORF1ab, herein referred to as SARS-CoV-2-miR-AS1. Our data show that the expression of this microRNA increases in a time course analysis of SARS-CoV-2 infected cells. Furthermore, enoxacin treatment enhances the accumulation of the mature SARS-CoV-2-miR-AS1 in SARS-CoV-2 infected cells, arguing for a Dicer-dependent processing of this small RNA. In silico analysis suggests that SARS-CoV-2-miR-AS1 targets a set of genes which are translationally repressed during SARS-CoV-2 infection. We experimentally validated that SARS-CoV-2-miR-AS1 targets FOS, thus repressing the AP-1 transcription factor activity in human cells.
first_indexed 2024-03-11T02:05:37Z
format Article
id doaj.art-b926b3451bab48e5b2f41c1ac7340d26
institution Directory Open Access Journal
issn 2311-553X
language English
last_indexed 2024-03-11T02:05:37Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Non-Coding RNA
spelling doaj.art-b926b3451bab48e5b2f41c1ac7340d262023-11-18T11:54:26ZengMDPI AGNon-Coding RNA2311-553X2023-05-01933310.3390/ncrna9030033A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 ActivityFrancesco Greco0Elisa Lorefice1Claudia Carissimi2Ilaria Laudadio3Fabiola Ciccosanti4Martina Di Rienzo5Francesca Colavita6Silvia Meschi7Fabrizio Maggi8Gian Maria Fimia9Valerio Fulci10Dipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyDipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyDipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyDipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS ‘L. Spallanzani’, 00149 Rome, ItalyDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS ‘L. Spallanzani’, 00149 Rome, ItalyDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS ‘L. Spallanzani’, 00149 Rome, ItalyDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS ‘L. Spallanzani’, 00149 Rome, ItalyDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS ‘L. Spallanzani’, 00149 Rome, ItalyDipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyDipartimento di Medicina Molecolare, Università di Roma “La Sapienza”, 00161 Rome, ItalyVirus-encoded microRNAs were first reported in the Epstein–Barr virus in 2004. Subsequently, a few hundred viral miRNAs have been identified, mainly in DNA viruses belonging to the <i>herpesviridae</i> family. To date, only 30 viral miRNAs encoded by RNA viruses are reported by miRBase. Since the outbreak of the SARS-CoV-2 pandemic, several studies have predicted and, in some cases, experimentally validated miRNAs originating from the positive strand of the SARS-CoV-2 genome. By integrating NGS data analysis and qRT-PCR approaches, we found that SARS-CoV-2 also encodes for a viral miRNA arising from the minus (antisense) strand of the viral genome, in the region encoding for ORF1ab, herein referred to as SARS-CoV-2-miR-AS1. Our data show that the expression of this microRNA increases in a time course analysis of SARS-CoV-2 infected cells. Furthermore, enoxacin treatment enhances the accumulation of the mature SARS-CoV-2-miR-AS1 in SARS-CoV-2 infected cells, arguing for a Dicer-dependent processing of this small RNA. In silico analysis suggests that SARS-CoV-2-miR-AS1 targets a set of genes which are translationally repressed during SARS-CoV-2 infection. We experimentally validated that SARS-CoV-2-miR-AS1 targets FOS, thus repressing the AP-1 transcription factor activity in human cells.https://www.mdpi.com/2311-553X/9/3/33microRNASARS-CoV-2FOSAP-1SARS-CoV-2-miR-AS1
spellingShingle Francesco Greco
Elisa Lorefice
Claudia Carissimi
Ilaria Laudadio
Fabiola Ciccosanti
Martina Di Rienzo
Francesca Colavita
Silvia Meschi
Fabrizio Maggi
Gian Maria Fimia
Valerio Fulci
A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
Non-Coding RNA
microRNA
SARS-CoV-2
FOS
AP-1
SARS-CoV-2-miR-AS1
title A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
title_full A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
title_fullStr A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
title_full_unstemmed A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
title_short A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
title_sort microrna arising from the negative strand of sars cov 2 genome targets fos to reduce ap 1 activity
topic microRNA
SARS-CoV-2
FOS
AP-1
SARS-CoV-2-miR-AS1
url https://www.mdpi.com/2311-553X/9/3/33
work_keys_str_mv AT francescogreco amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT elisalorefice amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT claudiacarissimi amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT ilarialaudadio amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT fabiolaciccosanti amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT martinadirienzo amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT francescacolavita amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT silviameschi amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT fabriziomaggi amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT gianmariafimia amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT valeriofulci amicrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT francescogreco micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT elisalorefice micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT claudiacarissimi micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT ilarialaudadio micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT fabiolaciccosanti micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT martinadirienzo micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT francescacolavita micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT silviameschi micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT fabriziomaggi micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT gianmariafimia micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity
AT valeriofulci micrornaarisingfromthenegativestrandofsarscov2genometargetsfostoreduceap1activity